Cochrane Reviews
ابوریحان لصناعة الأدویة
2018 – Interventions for improving adherence to iron chelation therapy in people with sickle cell disease or thalassaemia (Review) – Cochrane
2017 – Bollig C- Deferasirox for managing iron overload in people with thalassaemia (Review) – Cochrane
2016 – Fortin PM – Interventions for improving adherence to iron chelation therapy in people with sickle cell disease or thalassaemia (Protocol) – Cochrane